N. Sherwi

发表

Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE‐HF, COACH galectin‐3 substudy, HF‐ACTION nuclear substudy, DAD‐HF, and MARVEL‐1

J. Cleland, M. Lainscak, A. Coletta, 2010, European journal of heart failure.

Personalizing biomarker strategies in heart failure with galectin-3.

K. Wong, N. Sherwi, Shermin Merali, 2012, Future cardiology.

Old and newer biomarkers in heart failure: from pathophysiology to clinical significance

P. Pellicori, L. Buga, A. Joseph, 2013, Journal of cardiovascular medicine.

Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure

A. Rigby, J. Cleland, E. Lukaschuk, 2012, Heart Failure Reviews.

IVC diameter in patients with chronic heart failure: relationships and prognostic significance.

J. Cleland, A. Clark, Jufen Zhang, 2013, JACC. Cardiovascular imaging.

The Prevalence of Extra-cranial Carotid Artery Disease in Chronic Heart Failure

J. Cleland, A. Clark, Jufen Zhang, 2015 .

Development and course of heart failure after a myocardial infarction in younger and older people

Azam Torabi, A. Rigby, J. Cleland, 2014, Journal of geriatric cardiology : JGC.

Influence of case definition on incidence and outcome of acute coronary syndromes

A. Rigby, J. Cleland, E. Kilpatrick, 2016, Open Heart.

The relationship of QRS morphology with cardiac structure and function in patients with heart failure

J. Cleland, E. Lukaschuk, A. Clark, 2015, Clinical Research in Cardiology.